Home > Qtrly Results > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Quarterly Results Analysis [Mar2026]

COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹3,771 Cr ₹3,901 Cr ₹6,047 Cr ₹3,264 Cr ₹3,256 Cr ₹3,388 Cr ₹3,434 Cr ₹3,244 Cr
Expenses ₹3,008 Cr ₹3,031 Cr ₹3,687 Cr ₹2,684 Cr ₹2,695 Cr ₹2,787 Cr ₹2,832 Cr ₹2,656 Cr
Operating Income ₹763 Cr ₹870 Cr ₹2,360 Cr ₹581 Cr ₹561 Cr ₹600 Cr ₹602 Cr ₹588 Cr
Other Income ₹189 Cr ₹44 Cr ₹201 Cr ₹26 Cr ₹12 Cr ₹31 Cr ₹39 Cr ₹31 Cr
Interest ₹43 Cr ₹41 Cr ₹66 Cr ₹58 Cr ₹67 Cr ₹52 Cr ₹48 Cr ₹40 Cr
Depreciation ₹148 Cr ₹154 Cr ₹141 Cr ₹130 Cr ₹125 Cr ₹123 Cr ₹120 Cr ₹118 Cr
Profit Before Tax ₹388 Cr ₹534 Cr ₹967 Cr ₹96 Cr ₹8 Cr ₹456 Cr ₹473 Cr ₹462 Cr
Profit After Tax ₹301 Cr ₹403 Cr ₹610 Cr ₹47 Cr ₹4 Cr ₹348 Cr ₹354 Cr ₹340 Cr
EPS ₹10.68 ₹14.29 ₹21.63 ₹1.66 ₹0.16 ₹12.33 ₹12.55 ₹12.06
Industry Peers & Returns1W1M1Y
GLENMARK PHARMACEUTICALS 0.7% -5.4% 68%
SUN PHARMACEUTICAL INDUSTRIES -2.4% 3% 9.6%
DIVIS LABORATORIES -3.3% 3.5% 4.9%
TORRENT PHARMACEUTICALS -2% 5% 43.1%
CIPLA -0% 6.9% -4.5%
DR REDDYS LABORATORIES -0.3% -3.8% 7.3%
MANKIND PHARMA -4.1% 4.8% -0.6%
LUPIN -0.3% -1.3% 15%
ZYDUS LIFESCIENCES 3.7% 18.3% 19.6%

GLENMARK PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-3.33 %

Y-o-Y

15.80 %

Quarters Revenues % Change
Mar2026 ₹3,771 Cr
-3.33
Dec2025 ₹3,901 Cr
-35.49
Sep2025 ₹6,047 Cr
85.23
Jun2025 ₹3,264 Cr
0.25
Mar2025 ₹3,256 Cr
-3.88
Dec2024 ₹3,388 Cr
-1.35
Sep2024 ₹3,434 Cr
5.84
Jun2024 ₹3,244 Cr -

GLENMARK PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-12.32 %

Y-o-Y

35.93 %

Quarters Operating Profit % Change
Mar2026 ₹763 Cr
-12.32
Dec2025 ₹870 Cr
-63.14
Sep2025 ₹2,360 Cr
306.45
Jun2025 ₹581 Cr
3.47
Mar2025 ₹561 Cr
-6.53
Dec2024 ₹600 Cr
-0.28
Sep2024 ₹602 Cr
2.33
Jun2024 ₹588 Cr -
Operating Margins
Q-o-Q

-9.33 %

Y-o-Y

17.35 %

Quarters Operating Margin% % Change
Mar2026 20.22%
-9.33
Dec2025 22.3%
-42.85
Sep2025 39.02%
119.46
Jun2025 17.78%
3.19
Mar2025 17.23%
-2.77
Dec2024 17.72%
1.08
Sep2024 17.53%
-3.31
Jun2024 18.13% -

GLENMARK PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-25.27 %

Y-o-Y

6,773.15 %

Quarters Profit After Tax % Change
Mar2026 ₹301 Cr
-25.27
Dec2025 ₹403 Cr
-33.94
Sep2025 ₹610 Cr
1,199.54
Jun2025 ₹47 Cr
971.46
Mar2025 ₹4 Cr
-98.74
Dec2024 ₹348 Cr
-1.82
Sep2024 ₹354 Cr
4.19
Jun2024 ₹340 Cr -
PAT Margins
Q-o-Q

-22.73 %

Y-o-Y

6,046.15 %

Quarters PAT Margin(%) % Change
Mar2026 7.99 %
-22.73
Dec2025 10.34 %
2.38
Sep2025 10.1 %
601.39
Jun2025 1.44 %
1,007.69
Mar2025 0.13 %
-98.73
Dec2024 10.27 %
-0.48
Sep2024 10.32 %
-1.62
Jun2024 10.49 % -

GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-25.26 %

Y-o-Y

6,575.00 %

Quarters EPS % Change
Mar2026 ₹10.68
-25.26
Dec2025 ₹14.29
-33.93
Sep2025 ₹21.63
1,203.01
Jun2025 ₹1.66
937.50
Mar2025 ₹0.16
-98.70
Dec2024 ₹12.33
-1.75
Sep2024 ₹12.55
4.06
Jun2024 ₹12.06 -

You may also like the below Video Courses